Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/25/14 → 3/25/17 |
Funding
- Ergomed Clinical Research Inc. (Prot #AEZS-108-050 // Prot #AEZS-108-050)
- Æterna Zentaris Inc. (Prot #AEZS-108-050 // Prot #AEZS-108-050)
Prot #AEZS-108-050: Randomized controlled study comparing AEZS-108 with doxorubicin as second line therapy for locally advanced, recurrent or metastatic endometrial cancer
- Pineda, Mario Javier (PD/PI)
Project: Research project